Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Emergency use authorization Experimental Vaccine Apr/02/2021 33 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/31/2021 40 44
Berberine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/22/2021 3 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Mar/19/2021 23 7
Glycyrrhizic acid Potential treatment - pre-clinical evidence Natural product Antiviral Mar/12/2021 4 0
Theaflavin gallate Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021 2 0
Pyronaridine Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021 3 0
Baicalin Potential treatment - pre-clinical evidence Natural product Antiviral Feb/16/2021 4 0